Clinical Trials Browser

Withdrawn × OTHER × Introns × Clear all

NCT02615574 2017-09-26

A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT01860742 2016-04-05

CASTOR

Phase 3 Withdrawn

Neuroendocrine Tumors

NCT00293527 2013-05-23

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

Phase 2 Withdrawn

Kidney Neoplasms, Neoplasm Metastasis

NCT01409187 2012-01-26

IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma

Phase 1/2 Withdrawn

Melanoma

NCT00963664 2009-09-09

Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma

Phase 2 Withdrawn

Melanoma